The 1st Annual Winter Update in Clinical and Laboratory Medicine: Faculty

Annual Summer Update in Clinical Immunology, Microbiology, and Infectious Diseases

July 14 - 18, 2008, in Jackson Hole, Wyoming

Sponsored By: ARUP Laboratories | The University of Utah School of Medicine | The Department of Pathology | Division of Clinical Pathology

Course Directors

Professor and Associate Chair of Pathology
Professor of Pediatrics and Adjunct Professor of Medicine
Head, Division of Clinical Pathology
University of Utah School of Medicine
Senior Technical Vice President & Group Medical Director
Laboratories of Immunology and Infectious Diseases
ARUP Laboratories

Laboratory Diagnosis of Immune Deficiencies
Chronic Granulomatous Disease

Harry R. Hill, M.D.

Associate Professor of Pathology
University of Utah School of Medicine
Medical Director, Molecular Genetics
University of Utah School of Medicine
Molecular Pathology Laboratory
ARUP Laboratories

Molecular Analysis of Developmental Delay
Cystic Fibrosis Testing

Elaine Lyon, Ph.D.

Professor of Pathology
University of Utah School of Medicine
Medical Director, Automated Core Laboratory and the Chemistry Group
ARUP Laboratories

Tumor Markers
Cardiovascular Risk Factorss

William L. Roberts,
M.D., Ph.D.

Special Guests

Fred S. Apple, Ph.D. Professor of Laboratory Medicine Department of Laboratory Medicine and Pathology University of Minnesota Medical Director, Clinical Laboratories Medical Director, Clinical Chemistry and Toxicology Laboratories Hennepin County Medical Center	Cardiac Troponins and Acute Coronary Syndrome Natriuretic Peptides and Heart Failure
Karen E. Weck, M.D. Associate Professor of Pathology and Laboratory Medicine Director, Molecular Genetics Laboratory University of North Carolina at Chapel Hill	Bringing Genetics to Clinical Medicine: Primary Ciliary Dyskinesia Bringing Genetics to Clinical Medicine: Pharmacogenetic Efforts

Faculty

Edward Ashwood, M.D. Professor of Pathology University of Utah School of Medicine Senior Vice President and Director of Laboratories Chief Medical Officer ARUP Laboratories	Maternal Serum Screening
Pinar Bayrak-Toydemir, M.D., Ph.D. Assistant Professor of Pathology University of Utah School of Medicine Assistant Medical Director, Molecular Genetics Laboratory ARUP Laboratories	Analyzing Full Genes for Genetic
Julio C. Delgado, M.D., M.S. Assistant Professor of Pathology University of Utah School of Medicine Medical Director, Protein Immunology Laboratory ARUP Laboratories	Diagnosis of Monoclonal Gammopathies
Mark A. Fisher, Ph.D. Research Instructor University of Utah School of Medicine Assistant Medical Director, Microbiology Laboratory ARUP Laboratories	Susceptibility Testing
Elizabeth L. Frank, Ph.D. Assistant Professor of Pathology Medical Director, Analytic Biochemistry Laboratory Co-Director, Trace Elements and Calculi ARUP Laboratories	Neuroendocrine Tumors
Adi V. Gundlapalli, M.D., Ph.D. Assistant Professor of Pathology Medical Director, Analytic Biochemistry Laboratory Co-Director, Trace Elements and Calculi ARUP Laboratories	Overview of Bioterrorism Agents
David R. Hillyard, M.D. Associate Professor of Pathology University of Utah School of Medicine Director, Molecular Infectious Disease Testing ARUP Laboratories	Hepatitis C
Brian Jackson, M.D., M.S. Assistant Professor of Pathology Medical Director of Informatics ARUP Laboratories	Laboratory Test Utilization
Peter E. Jensen, M.D. Professor and Chair Department of Pathology University of Utah School of Medicine	The Vasculitidies
Christine M. Litwin, M.D. Professor of Pathology University of Utah School of Medicine Medical Director, Microbial Immunology Associate Director, Laboratory of Immunology ARUP Laboratories	Update in Microbial Serology
John M. Matsen, M.D. Professor Emeritus of Pathology and Pediatrics University of Utah School of Medicine	Gram Positive Bacilli
Gwendolyn A. McMillin, Ph.D., D.A.B.C.C. Assistant Professor of Pathology Medical Director, Clinical Toxicology and the Trace Elements Laboratories Co-Director, Pharmacogenomics ARUP Laboratories	Pharmacogenomics
A. Wayne Meikle, M.D. Professor of Medicine, Endocrinology, and Pathology University of Utah School of Medicine Medical Director, Endocrinology and Automated Endocrinology Laboratory ARUP Laboratories	Osteoporosis and the Laboratory
Rong Mao, M.D. Assistant Professor of Pathology University of Utah School of Medicine Co-Medical Director, Molecular Genetics Molecular Pathology Laboratory ARUP Laboratories	Genetics of Hearing Loss
Marzia Pasquali, Ph.D., FACMG Associate Professor of Pathology University of Utah School of Medicine Medical Director, Biochemical Genetics Laboratory Medical Director, Supplemental Newborn Screening Laboratory ARUP Laboratories	Expanded Newborn Screening
Cathy A. Petti, M.D. Assistant Professor of Pathology and Medicine University of Utah School of Medicine Medical Director, Infectious Disease Laboratory ARUP Laboratories	Bacterial Identification by Sequencing
Genevieve Pont-Kingdon, Ph.D. Senior Scientist, Molecular Genetics ARUP Laboratories	Molecular Haplotyping
Larry G. Reimer, M.D. Professor of Pathology and Medicine Head, Section of Clinical Microbiology University of Utah School of Medicine Director, Clinical Microbiology Laboratories and Infectious Diseases Salt Lake Veterans Administration Medical Center	HIV Infection
Alan L. Rockwood, Ph.D. Associate Professor of Pathology University of Utah School of Medicin e Adjunct Research Collaborator, Chemistry Department, B.Y.U. Scientific Director, Mass Spectrometry Laboratory ARUP Laboratories	Mass Spectrometry
Anne Tebo, Ph.D. Assistant Professor of Pathology Assistant Medical Director, Autoimmune Immunology Laboratory ARUP Laboratories	Laboratory Diagnosis of Autoimmune Disease
Carl T. Wittwer, M.D., Ph.D. Professor of Pathology University of Utah School of Medicine Medical Director, Advanced Technology Group ARUP Laboratories	Gene Scanning by High Resolution Melting Analysis

Faculty Disclosure

The University of Utah School of Medicine adheres to ACCME standards regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships, if any, will be made known at the activity. Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs, devices, or equipment in their presentations.